meptazinol has been researched along with Amentia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, HZ; Ge, XX; Jiang, P; Le, WD; Lu, Y; Qiu, ZB; Shao, BY; Sun, J; Wang, H; Xia, Z; Xie, Q; Zhang, WW | 1 |
1 other study(ies) available for meptazinol and Amentia
Article | Year |
---|---|
Meserine, a novel carbamate AChE inhibitor, ameliorates scopolamine-induced dementia and alleviates amyloidogenesis of APP/PS1 transgenic mice.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloidosis; Animals; Cell Line, Tumor; Cholinesterase Inhibitors; Dementia; Disease Models, Animal; Drug Administration Schedule; Humans; Maze Learning; Meptazinol; Mice; Mice, Transgenic; Neuroblastoma; Phenylcarbamates; Presenilin-1; RNA, Messenger; Scopolamine | 2014 |